Pharmexa-Epimmune and Ichor Medical Systems enter into a collaborative agreement
20-Dec-2006 -
Pharmexa-Epimmune, a subsidiary of Pharmexa A/S, and Ichor Medical Systems have entered into a collaborative agreement and have agreed to licensing terms for Pharmexa's HER-2 DNA AutoVacTM. This is the second time Pharmexa agrees to grant a non-exclusive license to the HER-2 DNA AutoVacTM ...
antibodies
breast cancer
Pharmexa
+2